This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In LHC Group, Inc. To Contact The Firm

NEW YORK, July 6, 2012 /PRNewswire/ --  Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at LHC Group, Inc. ("LHC" or the "Company") (NASDAQ: LHCG).

(Logo:  http://photos.prnewswire.com/prnh/20120119/MM38856LOGO )

The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that the reported growth in LHC's home-based healthcare segment was created, in large part, by defrauding the Medicare home health program at the expense of taxpayers.

On April 26, 2010, The Wall Street Journal published an article entitled "Home Care Yields Medicare Bounty" which detailed an analysis of Medicare payments to home health-care companies (such as LHC) and questioned whether some companies were taking advantage of the Medicare reimbursement system.  In May 2010, the Senate Finance Committee launched an investigation into the allegations contained within this article, and shortly thereafter, LHC issued a press release announcing that the Company had received a request for information from the Committee.  

The Senate Finance Committee released a report on October 3, 2011 analyzing the home therapy practices of LHC and other companies in the industry.  That report concluded that "[t]he home health therapy practices identified at [LHC] . . . at best represent abuses of the Medicare home health program.  At worst, they may be examples of . . . defrauding the Medicare home health program at the expense of taxpayers."  Following the release of this report, stock in LHC fell from $17.06 to $15.01 per share, a two-day decline of 12%.

Finally, on October 26, 2011, the Company issued a press release announcing that it was lowering its earnings forecast.  On this news, the price of LHC's stock dropped over 15%, closing at $15.89 on October 27, 2011, from a previous close of $18.84.

Request more information now by clicking here:  www.faruqilaw.com/LHCG.  There is no cost or obligation to you.

Take Action

If you purchased LHC securities between July 30, 2008 and October 26, 2011 and would like to discuss your legal rights, visit www.faruqilaw.com/LHCG.  You can also contact us by calling Juan Monteverde, Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to jmonteverde@faruqilaw.com, rgonnello@faruqilaw.com or fmcconville@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding LHC's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential matter.FARUQI & FARUQI, LLP369 Lexington Avenue, 10th Floor New York, NY 10017Attn:  Juan Monteverde, Esq. jmonteverde@faruqilaw.com Richard Gonnello, Esq. rgonnello@faruqilaw.com Francis McConville, Esq. fmcconville@faruqilaw.comTelephone: (877) 247-4292 or (212) 983-9330

SOURCE Faruqi & Faruqi, LLP

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,976.31 +263.65 1.49%
S&P 500 2,086.24 +25.22 1.22%
NASDAQ 4,947.4410 +56.2220 1.15%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs